# Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

> **NCT03967886** · PHASE3 · COMPLETED · sponsor: **Yooyoung Pharmaceutical Co., Ltd.** · enrollment: 170 (actual)

## Conditions studied

- Non-erosive Reflux Disease

## Interventions

- **DRUG:** YYD601 20mg
- **DRUG:** Nexium 20mg
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03967886
- **Lead sponsor:** Yooyoung Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-05-27
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03967886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03967886, "Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03967886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*